Accelerate your research and develop with access to elite Fractional Science Leaders at every stage, AI-enabled research and AI tool integration, and the right pathway from idea to scale-up.
Flexible, executive PhD-level scientific guidance to formulate ideas and navigate complex R&D roadmaps.
Converting raw analytical measurements into defensible conclusions across multi-technique suites.
Structured literature and competitive landscape analysis evaluated from a mechanism-first perspective.
Independent technical evaluations for M&A, investments, and licensing to de-risk core scientific claims.
Interdisciplinary research bridging materials chemistry, degradation kinetics, and biological interactions.
Rigorously structured documentation tailored for internal engineering teams, investors, and regulatory bodies.
Deep-dive market analyses that align technical feasibility with commercial realities prior to capital deployment.
Bypassing generic hype to deploy practical, high-impact AI tools matched directly to your existing R&D workflows.
Bridging the gap from isolated prototypes to secure, multi-user applications integrated into core infrastructure.
Applying targeted machine learning models to accelerate experimental cycles and property predictions.
Translating lab discoveries into defensible intellectual property assets in tandem with legal teams.
Sourcing, vetting, and managing external contract labs and testing facilities to optimize R&D expenditure.
Choose the level of support your science needs now. Start focused and expand when the evidence calls for it.
01 / ONGOING PARTNERSHIP
Embedded scientific guidance for teams that need consistent technical direction and decision support with full access to the entire Catalyst Network.
Expert CSOs, CTOs, VPs, Directors, or PIs to help you move quickly.
02 / PROJECT DEFINITION
Facing an immediate technical challenge? The Catalyst team will conduct a focused review of your technical goal, constraints, risks, and the experiments most likely to move it forward.
03 / TARGETED EXPERTISE
Direct access to a subject-matter expert for a technical question, review, or time-sensitive decision.
Executive Summary Specialty chemical and active pharmaceutical ingredient (API) manufacturing stands at a structural crossroads. For over a century, stirred-tank batch reactors...
Executive Summary: Strategic Transition from PFAS Chemistries to Rational Fluorine-Free Alternatives 1. Executive Context & The Paradigm Shift Global regulatory frameworks—led by...
Want to download the PDF to read on the go? Download the PDF here. Executive Summary The global chemical industry stands at...
